Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT05840055

Completed

ACT with NMOSD Patients and Caregivers Pilot Study

NMO Spectrum Disorder
NCT05663541

Completed

Validity and Reliability of Lower Extremity Position Test in Patients with Multiple Sclerosis

Multiple Sclerosis | Proprioceptive Disorders | Reliability | Validity | Sensory Impairments
NCT06603272

Completed

Comparison of Short- and Long-term Efficacy of Robotic Versus Laparoscopic Gastrectomy in High-risk Patients With Gastric Cancer: a Nationwide, Multicentre Cohort Study (RL2023)

Patients With More Than or Equal to One of the Following Criteria Were Defined as High-risk Patients
NCT03766347

Completed

Pediatric NMOSD Observational Study

Neuromyelitis Optica | NMO Spectrum Disorder
NCT00493298

Completed

Tysabri Observational Program (TOP)

Relapsing-Remitting Multiple Sclerosis
NCT06251830

Completed

Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?

Epilepsy | Multiple Sclerosis | Neurodegenerative Diseases | Neurodevelopmental Disorders | Brain Tumor
NCT01013311

Completed

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

Cardiomyopathy | Sarcoidosis of the Heart
NCT03244696

Completed

Behavior and Activity Monitoring in MS

Relapsing-Remitting Multiple Sclerosis
NCT00854295

Completed

Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee

Osteoarthritis | Traumatic Arthritis | Avascular Necrosis of the Femoral Condyle | Moderate Varus | Valgus | Flexion Deformities
NCT05494619

Withdrawn

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)

Guillain-Barré Syndrome
NCT03870048

Completed

tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis

Multiple Sclerosis
NCT04227470

Completed

A Study of HBM9161 in NMOSD Patients

NMO Spectrum Disorder
NCT02753088

Completed

Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis
NCT04032158

Terminated

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

Relapsing-remitting Multiple Sclerosis
NCT01790269

Terminated

Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod

Relapsing-Remitting Multiple Sclerosis
NCT04944251

Completed

Regular Exercise Improves Physical Capacity and Promotes Neurotrophins in Patients With Multiple Sclerosis

Multiple Sclerosis | Neuro-Degenerative Disease | Exercise Intervention
NCT00641537

Completed

CLARITY Extension Study

Relapsing-Remitting Multiple Sclerosis
NCT01930708

Completed

A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes (PROTEC)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
NCT04287244

Unknown

Transcutaneous Direct Current Stimulation of the Spinal Cord for Treatment of Spasticity in Multiple Sclerosis

Spastic Parapareses
NCT00787722

Completed

Hematopoietic Stem Cell Transplant in Devic's Disease

Devic's Disease
NCT00203021

Completed

Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

Relapsing-Remitting Multiple Sclerosis
NCT02692898

Terminated

Biomarker Analysis of Central Nervous System Tumors

Central Nervous System Neoplasms | Brain Cancer | Neoplasms, Brain | Primary Brain Neoplasms | Cancer of the Brain
NCT03536299

Unknown

Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis (MS)

Multiple Sclerosis | Cognitive Impairment | Gait Disorders, Neurologic
NCT02687919

Completed

Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-remitting
NCT02720107

Completed

Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)

Relapsing-remitting Multiple Sclerosis
NCT01838668

Completed

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
NCT00882999

Completed

A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Relapsing-Remitting Multiple Sclerosis
NCT01051349

Completed

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis (SELECTED)

Relapsing-Remitting Multiple Sclerosis
NCT01381354

Completed

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Multiple Sclerosis
NCT03302442

Completed

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis (COMP-RMS)

Relapsing-remitting Multiple Sclerosis
NCT02125604

Completed

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany (TOLERATE)

Relapsing-Remitting Multiple Sclerosis
NCT02689726

Terminated

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
NCT01564511

Completed

Effects of Electromechanical Gait Trainer in Patients With Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis
NCT00870740

Completed

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis (SELECTION)

Relapsing-Remitting Multiple Sclerosis
NCT01064401

Completed

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis ((DECIDE))

Relapsing-Remitting Multiple Sclerosis
NCT01884935

Completed

PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

Relapsing-Remitting Multiple Sclerosis
NCT01930799

Completed

Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns

Multiple Sclerosis | Urinary Bladder Diseases
NCT01890655

Completed

Extension Study of MT-1303

Relapsing-remitting Multiple Sclerosis
NCT01977287

Completed

Walking With FES or AFO in People With MS With Foot Drop

Multiple Sclerosis | Foot Drop
NCT01212094

Terminated

Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)

Multiple Sclerosis
NCT01371760

Completed

BRAVE-DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosis) (BRAVE-DREAMS)

Multiple Sclerosis | Venous Insufficiency
NCT00004833

Terminated

Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome

Guillain-Barre Syndrome
NCT01144052

Completed

Natalizumab De-escalation With Interferon Beta-1b

Relapsing-remitting Multiple Sclerosis
NCT01142518

Completed

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone (RETURN)

Relapsing-Remitting Multiple Sclerosis
NCT01701856

Terminated

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis
NCT01201343

Completed

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients (SEPTIME)

Multiple Sclerosis, Relapsing, Remitting
NCT01842191

Completed

Efficacy of Fish Oil in Multiple Sclerosis (EFOMS)

Relapsing- Remitting Multiple Sclerosis
NCT00480181

Completed

Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis

Multiple Sclerosis | Neuropathic Pain
NCT00289978

Completed

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)

Relapsing-remitting Multiple Sclerosis
NCT01040117

Completed

Sensori-motor Integration Training in Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations